Analyst Price Targets — BCAB
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 23, 2024 6:20 am | Reni Benjamin | JMP Securities | $250.00 | $114.00 | TheFly | BioAtla price target lowered to $5 from $12 at JMP Securities |
Latest News for BCAB
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
Context announces buyout of CT-202 future milestones and royalties in exchange for a fully paid-up, non-terminable license
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BCAB.
U.S. House Trading
No House trades found for BCAB.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.